首页> 外文OA文献 >Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib

【2h】

Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib

机译：用嵌合抗原受体T细胞疗法治疗T315i BCR-ABL突变淋巴喷砂阶段慢性髓性白血病的成功治疗达塞替尼

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hao Zhang; Yongxian Hu; Alex H. Chang; He Huang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells [J] . Qu Changju, Li Zheng, Kang Liqing, Bone marrow transplantation . 2019,第7期

机译：通过CD19针对嵌合抗原受体T细胞成功治疗两种复发/难治性T（8; 21）急性髓性白血病患者
2. Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation [J] . KawanoN., OkudaS., YoshidaS., International journal of hematology . 2011,第6期

机译：伊马替尼联合化学疗法和大剂量化学疗法同种异体骨髓干细胞移植术联合bcr / abl转录本成功治疗慢性粒细胞性白血病淋巴样细胞危机
3. Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation [J] . Noriaki Kawano, Shinya Okuda, Shuro Yoshida, International Journal of Hematology . 2011,第6期

机译：伊马替尼联合化学疗法和大剂量化学疗法同种异体骨髓干细胞移植成功通过额外的bcr / abl转录本成功治疗慢性粒细胞性白血病淋巴样细胞危机
4. REMOVAL OF MYELOID CELLS FROM AUTOLOGOUS LEUKOCYTES USED FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL MANUFACTURING IMPROVES FINAL PRODUCT CONSISTENCY AND YIELDS [C] . David Stroncek, Daniel W. Lee, Marianna Sabatino, Scale-up and manufacturing of cell-based therapies V . 2017

机译：从用于嵌合抗原受体（CAR）T细胞制造的自体白细胞去除髓样细胞可改善最终产品的一致性和产量
5. Suppression of BCR-ABL by siRNA-loaded nanoparticles for the treatment of Chronic Myeloid Leukemia [D] . Gavrilov, Kseniya Eugene. 2015

机译：载有siRNA的纳米颗粒抑制BCR-ABL用于治疗慢性粒细胞白血病
6. Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib [O] . Hao Zhang, Yongxian Hu, Alex H. Chang, 2020

机译：嵌合抗原受体T细胞疗法联合达沙替尼成功治疗T315I BCR-ABL突变型淋巴母细胞期慢性粒细胞白血病
7. Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells [O] . Changju Qu, Zheng Li, Liqing Kang, 2019

机译：通过CD19针对嵌合抗原受体T细胞成功治疗两种复发/难治性T（8; 21）急性髓性白血病患者

Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib

著录项

引文网络

相似文献

相关主题

期刊订阅